Transitional care of adolescents with inflammatory bowel disease to adult services varies widely across Australia and New Zealand
- PMID: 38268957
- PMCID: PMC10805482
- DOI: 10.1002/jgh3.13032
Transitional care of adolescents with inflammatory bowel disease to adult services varies widely across Australia and New Zealand
Abstract
Background and aim: Children and adolescents account for approximately 14% of inflammatory bowel disease (IBD) diagnoses. At an appropriate age and level of development adolescents with IBD have their care transferred from the pediatric to adult clinical team during a process termed "transition". The study aim was to survey pediatric gastroenterologists throughout Australasia to identify commonality in the transition process to contribute to standardized guideline development.
Methods: A descriptive survey captured key variables: transition clinic format, process and infrastructure, transition assessments, and guidelines. The survey was distributed electronically to 59 Pediatric Gastroenterologists throughout Australasia in January 2023.
Results: Seventeen (29%) clinicians completed the survey: Australia 13 (76%). New Zealand 4 (24%). Thirteen (76%) respondents had access to a dedicated IBD transition clinic. Adolescents attended transition clinics 1-7 times, and the main processes transferred were: prescription provision, biologic appointments, and adult team contacts. Transition was first discussed age 13-15 years (53%), or 16-18 years (47%), with the main discussion topics including: continuing adherence (88%), smoking (59%), alcohol use (59%), recreational drug use (59%). Transition readiness assessments were done infrequently (24%). The minority (24%) used formal guidelines to inform the transition process, but 15 (88%) considered the development of a standardized Australasian guideline as beneficial/extremely beneficial.
Conclusions: This survey highlighted that transition care for adolescents with IBD is variable across Australasia. Australasian guideline development may optimize the transition process for adolescents with IBD and improve their longitudinal outcomes.
Keywords: IBD; adolescents; colitis; crohn's disease; guidelines; transition.
© 2024 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Figures




Similar articles
-
Pediatric to Adult Transition in Inflammatory Bowel Disease: Consensus Guidelines for Australia and New Zealand.Inflamm Bowel Dis. 2025 Feb 6;31(2):563-578. doi: 10.1093/ibd/izae087. Inflamm Bowel Dis. 2025. PMID: 38701328 Free PMC article.
-
A Cross-Sectional Survey on the Transitional Care of Adolescents with Inflammatory Bowel Disease in Hungary.J Pediatr Nurs. 2020 Nov-Dec;55:e279-e285. doi: 10.1016/j.pedn.2020.06.002. Epub 2020 Jul 3. J Pediatr Nurs. 2020. PMID: 32624314
-
Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease.Intern Med J. 2014 May;44(5):490-6. doi: 10.1111/imj.12402. Intern Med J. 2014. PMID: 24589174
-
European Crohn's and Colitis Organisation Topical Review on Transitional Care in Inflammatory Bowel Disease.J Crohns Colitis. 2017 Sep 1;11(9):1032-1038. doi: 10.1093/ecco-jcc/jjx010. J Crohns Colitis. 2017. PMID: 28158494
-
A consensus statement on health-care transition for childhood-onset inflammatory bowel disease patients.Pediatr Int. 2022 Jan;64(1):e15241. doi: 10.1111/ped.15241. Pediatr Int. 2022. PMID: 35895501 Review.
Cited by
-
Pediatric to Adult Transition in Inflammatory Bowel Disease: Consensus Guidelines for Australia and New Zealand.Inflamm Bowel Dis. 2025 Feb 6;31(2):563-578. doi: 10.1093/ibd/izae087. Inflamm Bowel Dis. 2025. PMID: 38701328 Free PMC article.
References
-
- Armengol‐Debeir L, Andre JM, Aroichane I et al. Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988–2011): A Population‐Based Study of French Adolescents. Am. J. Gastroenterol. 2018; 113: 265–272. - PubMed
-
- Burgess CJ, Henderson P, Jones G‐R, Lees CW, Wilson DC. Paediatric patients (less than age of 17 years) account for less than 1.5% of all prevalent inflammatory bowel disease cases. J. Pediatr. Gastroenterol. Nutr. 2020; 71: 521–523. - PubMed
-
- Su YH, Gupta SV, Day BA, Gearry BR. Rising incidence of inflammatory bowel disease in Canterbury, New Zealand. Inflamm. Bowel Dis. 2016; 22: 2238–2244. - PubMed
-
- Kelsen NJ, Baldassano NR. Inflammatory bowel disease: The difference between children and adults. Inflamm. Bowel Dis. 2008; 14: S9–S11. - PubMed
LinkOut - more resources
Full Text Sources